SCHEMBL30945261

SCHEMBL30945261

Cc1ccc(S(=O)(=O)O)cc1.Fc1cc(C(F)(F)F)ccc1OC1CNC1

nearest known ligand 0.46

Known targets — ChEMBL curated mechanism

ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 13/20 0.43
HTR2C P28335 6/20 0.43
HTR2B P41595 6/20 0.43
HTR2A P28223 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HTR6 P50406 2/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27246554 0.89 CYP2D6 (0.41) SLC6A4HTR2CHTR2B
SCHEMBL30945291 0.84 FPR2 (0.48) SLC6A4HTR2CHTR2B
SCHEMBL19833874 0.84 CHRNA7 (0.42) MEN1KMT2AALDH1A1
SCHEMBL27246482 0.83 CYP2D6 (0.40) SLC6A4HTR2CHTR2B
SCHEMBL19409557 0.82 IDO1 (0.40) SLC6A4HTR2CHTR2BMEN1KMT2A
SCHEMBL21723111 0.79 HTR2C (0.44) SLC6A4HTR2CHTR2BMEN1KMT2A
SCHEMBL27246466 0.77 HRH1 (0.44) SLC6A4HTR2CHTR2B
SCHEMBL29712505 0.77 HTR2A (0.43) SLC6A4HTR2CHTR2AALDH1A1
SCHEMBL21723030 0.77 HTR2A (0.43) SLC6A4HTR2CHTR2AALDH1A1
SCHEMBL27144502 0.76 BCHE (0.48) SLC6A4HTR2CHTR2BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240199587-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2024-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199587-A1 HETEROCYCLIC COMPOUNDS CYP1B1, CYP1A1, CYP4B1 SLC6A4 4134/4885HTR2C 1158/4885HTR2B 361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.